Anthony Lembo
, Director of Clinical Research · Beth Israel Deaconess Medical Center
Credentials: · · · · · ·
History
- Present
Clinical Research · Beth Israel Deaconess Medical Center
1993–1996- 1990–1993
1986–1990- 1981–1985
Research
Gastroenterology · 2016 · 2,337 citations
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
BMJ · 2008 · Last of 17 authors · 851 citations
Rifaximin therapy for patients with irritable bowel syndrome without constipation
New England Journal of Medicine · 2011 · 750 citations
73 papers
- SB
55 papers
48 papers
46 papers
- PS
39 papers · 17 as a fellow
39 papers
27 papers
23 papers · 7 as a resident
Grants
- 2015–2021
Efficacy of Open-Label Placebo, Double-Blind Placebo, and Peppermint Oil in IBS
National Center for Complementary and Integrative Health · R01
Contact PI · $4.3M · Beth Israel Deaconess Medical Center
- 2005–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.2M · Beth Israel Deaconess Medical Center
Clinical trials
- 2024–2025
Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome
Principal investigator · Withdrawn
Anthony Lembo
- 2020–2024
Effect of a Low FODMAP Diet on SIBO Breath Test Positivity
Principal investigator · Terminated · Early phase 1
Beth Israel Deaconess Medical Center
- 2020–2022
SH-DS01 on Fecal Metagenomic Stability
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center
- 2020–2022
Crofelemer for Functional Diarrhea
Principal investigator · Terminated · Phase 4
Beth Israel Deaconess Medical Center